Asian Spine J.
2015 Dec;9(6):999-1000. 10.4184/asj.2015.9.6.999.
Erratum: Correction of Figures. The Time Course Changes in Bone Metabolic Markers after Administering the Anti-Receptor Activator of Nuclear Factor-Kappa B Ligand Antibody and Drug Compliance among Patients with Osteoporosis
- Affiliations
-
- 1Department of Orthopedic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
- 2Department of Orthopedic Surgery, National Hospital Organization Chiba Medical Center, Chiba, Japan.
- 3Department of Orthopedic Surgery, Teikyo University Chiba Medical Center, Chiba, Japan.
- KMID: 2131129
- DOI: http://doi.org/10.4184/asj.2015.9.6.999
Abstract
- There were some mistakes in the numerical values of the graphs.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The Time Course Changes in Bone Metabolic Markers after Administering the Anti-Receptor Activator of Nuclear Factor-Kappa B Ligand Antibody and Drug Compliance among Patients with Osteoporosis
- Denosumab (RANKL Inhibitor): A Potent Anti-Resorptive Agent
- Cellular Localization of RANKL and RANK Production in Giant Cell Tumors of Bone and Tendon Sheath by Immunohistochemistry
- Discontinuing Denosumab: Can It Be Done Safely? A Review of the Literature
- Regulation of NFATc1 in Osteoclast Differentiation
